5 reports of this reaction
1.5% of all NICKEL reports
#8 most reported adverse reaction
AGEUSIA is the #8 most commonly reported adverse reaction for NICKEL, manufactured by Boiron. There are 5 FDA adverse event reports linking NICKEL to AGEUSIA. This represents approximately 1.5% of all 344 adverse event reports for this drug.
Patients taking NICKEL who experience ageusia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
AGEUSIA is a less commonly reported adverse event for NICKEL, but still significant enough to appear in the safety profile.
In addition to ageusia, the following adverse reactions have been reported for NICKEL:
The following drugs have also been linked to ageusia in FDA adverse event reports:
AGEUSIA has been reported as an adverse event in 5 FDA reports for NICKEL. This does not prove causation, but indicates an association observed in post-market surveillance data.
AGEUSIA accounts for approximately 1.5% of all adverse event reports for NICKEL, making it a notable side effect.
If you experience ageusia while taking NICKEL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.